Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study
Classic

Association of the Hospital Readmissions Reduction Program implementation with readmission and mortality outcomes in heart failure.

Gupta A, Allen LA, Bhatt DL, et al. Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure. JAMA Cardiol. 2018;3(1):44-53. doi:10.1001/jamacardio.2017.4265.

Save
Print
August 20, 2018
Gupta A, Allen LA, Bhatt DL, et al. JAMA Cardiol. 2018;3(1):44-53.
View more articles from the same authors.
Readmissions are a focus of patient safety efforts, especially in light of Medicare's nonpayment policy. This retrospective, interrupted time-series analysis examined whether reduction in readmissions for heart failure led to any change in health outcomes. This study analyzed data from a national clinical registry of patients with heart failure admitted between 2006 and 2014, spanning the implementation of Medicare nonpayment. Similar to prior studies, there was a decline in readmission rates observed after implementation of penalties. In this cohort, researchers also observed increases in 30-day and 1-year risk-adjusted mortality. The authors conclude that penalties for readmissions may have unintended negative consequences for patient outcomes. A previous PSNet interview discussed the benefits and limitations of Medicare's nonpayment policy.
Save
Print
Cite
Citation

Gupta A, Allen LA, Bhatt DL, et al. Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure. JAMA Cardiol. 2018;3(1):44-53. doi:10.1001/jamacardio.2017.4265.